Expression of thymidylate synthase and thymidine phosphorylase in human breast carcinoma: Implication for method to detect expression of these molecules in clinic

Cancer Letters

Volumn 190, Issue 1, 2003, Pages 97-104

  Ogura, Osamu ^a   Kanzaki, Atsuko ^b   Bando, Hiroko ^c   Ogura, Tadashi ^a   Toi, Masakazu ^c   Takebayashi, Yuji ^b  

^a Ogura Memorial Hospital   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Breast carcinoma; Immunohistochemistry; Polymerase chain reaction; Thymidine phosphorylase; Thymidylate synthetase

Indexed keywords

FLUOROURACIL; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE;

ARTICLE; BREAST CANCER; CANCER TISSUE; CHEMOTHERAPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0037428873     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00098-8     Document Type: Article

References (26)

1. Iltzsch M.H., el Kouni M.H., Cha S. Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry. 24:1985;6799-6807.
2. Zimmerman M. Selective inhibition by deoxyglucosyl thymine of thymidine phosphorylases not catalyzing deoxyribosyl transfer. Biochem. Biophys. Res. Commun. 16:1964;600-603.
3. Desgranges C. The nasopharyngeal carcinoma and Epstein-Barr virus (EBV) specific IgA (author's transl). Pathol. Biol. (Paris). 29:1981;587-589.
4. Furukawa T., Yoshimura A., Sumizawa T., Haraguchi M., Akiyama S., Fukui K., Ishizawa M., Yamada Y. Angiogenic factor. Nature. 356:1992;668.
5. Haraguchi M., Miyadera K., Uemura K., Sumizawa T., Furukawa T., Yamada K., Akiyama S., Yamada Y. Angiogenic activity of enzymes. Nature. 368:1994;198.
6. Moghaddam A., Zhang H.T., Fan T.P., Hu D.E., Lees V.C., Turley H., Fox S.B., Gatter K.C., Harris A.L., Bicknell R. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc. Natl. Acad. Sci. USA. 92:1995;998-1002.
7. Takebayashi Y., Akiyama S., Akiba S., Yamada K., Miyadera K., Sumizawa T., Yamada Y., Murata F., Aikou T. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J. Natl. Cancer Inst. 88:1996;1110-1117.
8. Takebayashi Y., Miyadera K., Akiyama S., Hokita S., Yamada K., Akiba S., Yamada Y., Sumizawa T., Aikou T. Expression of thymidine phosphorylase in human gastric carcinoma. Jpn. J. Cancer Res. 87:1996;288-295.
9. Takebayashi Y., Natsugoe S., Baba M., Akiba S., Fukumoto T., Miyadera K., Yamada Y., Takao S., Akiyama S., Aikou T. Thymidine phosphorylase in human esophageal squamous cell carcinoma. Cancer. 85:1999;282-289.
10. Imazano Y., Takebayashi Y., Nishiyama K., Akiba S., Miyadera K., Yamada Y., Akiyama S., Ohi Y. Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. J. Clin. Oncol. 15:1997;2570-2578.
11. Fukuiwa T., Takebayashi Y., Akiba S., Matsuzaki T., Hanamure Y., Miyadera K., Yamada Y., Akiyama S. Expression of thymidine phosphorylase and vascular endothelial cell growth factor in human head and neck squamous cell carcinoma and their different characteristics. Cancer. 85:1999;960-969.
12. Toi M., Hoshina S., Taniguchi T., Yamamoto Y., Ishitsuka H., Tominaga T. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int. J. Cancer. 64:1995;79-82.
13. Takebayashi Y., Yamada K., Miyadera K., Sumizawa T., Furukawa T., Kinoshita F., Aoki D., Okumura H., Yamada Y., Akiyama S., Aikou T. The activity and expression of thymidine phosphorylase in human solid tumours. Eur. J. Cancer. 32A:1996;1227-1232.
14. O'Brien T.S., Fox S.B., Dickinson A.J., Turley H., Westwood M., Moghaddam A., Gatter K.C., Bicknell R., Harris A.L. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res. 56:1996;4799-4804.
15. Giatromanolaki A., Koukourakis M.I., Comley M., Kaklamanis L., Turley H., O'Byrne K., Harris A.L., Gatter K.C. Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer. J. Pathol. 181:1997;196-199.
16. Haraguchi M., Furukawa T., Sumizawa T., Akiyama S. Sensitivity of human KB cells expressing platelet-derived endothelial cell growth factor to pyrimidine antimetabolites. Cancer Res. 53:1993;5680-5682.
17. Patterson A.V., Zhang H., Moghaddam A., Bicknell R., Talbot D.C., Stratford I.J., Harris A.L. Increased sensitivity to the prodrug 5′-deoxy-5-fluorouridine and modulation of 5-fluoro-2′-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br. J. Cancer. 72:1995;669-675.
18. Kato Y., Matsukawa S., Muraoka R., Tanigawa N. Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with a platelet-derived endothelial cell growth factor thymidine phosphorylase cDNA. Br. J. Cancer. 75:1997;506-511.
19. Jackman A.L., Calvert A.H. Folate-based thymidylate synthase inhibitors as anticancer drugs. Ann. Oncol. 6:1995;871-881.
20. Rustum Y.M., Harstrick A., Cao S., Vanhoefer U., Yin M.B., Wilke H., Seeber S. Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors. J. Clin. Oncol. 15:1997;389-400.
21. Kornmann M., Link K.H., Lenz H.J., Pillasch J., Metzger R., Butzer U., Leder G.H., Weindel M., Safi F., Danenberg K.D., Beger H.G., Danenberg P.V. Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy. Cancer Lett. 118:1997;29-35.
22. Pestalozzi B.C., Peterson H.F., Gelber R.D., Goldhirsch A., Gusterson B.A., Trihia H., Lindtner J., Cortes-Funes H., Simmoncini E., Byrne M.J., Golouh R., Rudenstam C.M., Castiglione-Gertsch M., Allegra C.J., Johnston P.G. Prognostic importance of thymidylate synthase expression in early breast cancer. J. Clin. Oncol. 15:1997;1923-1931.
23. Leichman C.G., Lenz H.J., Leichman L., Danenberg K., Baranda J., Groshen S., Boswell W., Metzger R., Tan M., Danenberg P.V. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J. Clin. Oncol. 15:1997;3223-3229.
24. van Triest B., Pinedo H.M., Blaauwgeers J.L., van Diest P.J., Schoenmakers P.S., Voorn D.A., Smid K., Hoekman K., Hoitsma H.F., Peters G.J. Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer. Clin. Cancer Res. 6:2000;1063-1072.
25. Fox S.B., Engels K., Comley M., Whitehouse R.M., Turley H., Gatter K.C., Harris A.L. Relationship of elevated tumour thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF. Ann. Oncol. 8:1997;271-275.
26. Metzger R., Danenberg K., Leichman C.G., Salonga D., Schwartz E.L., Wadler S., Lenz H.J., Groshen S., Leichman L., Danenberg P.V. High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with non-response to 5-fluorouracil. Clin. Cancer Res. 4:1998;2371-2376.